Evidence map›Paper›PMID 17592518›Full record

ArticleBritish journal of pharmacology2007

Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.

E Luccini, V Musante, E Neri, M Brambilla Bas, P Severi, M Raiteri, A Pittaluga

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Synaptosomes and Metamodulation of Receptors.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  4. Review
  5. Review
  6. Zerumbone Modulates αFrontiers in pharmacology · 2020
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Presynaptic mGlu1 Receptors Control GABAFrontiers in molecular neuroscience · 2018
    Article
  13. Review
  14. Review
  15. CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. MicroRNA-19b associates with Ago2 in the amygdala following chronic stress and regulates the adrenergic receptor beta 1.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

E LucciniPharmacology and Toxicology Section, Department of Experimental Medicine, University of Genoa, Viale Cembrano 4, Genoa 16148, Italy.
V Musante
E Neri
M Brambilla Bas
P Severi
M Raiteri
A Pittaluga
University of Genoa · ITEnte Ospedaliero Ospedali Galliera · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeElectrophysiological studies described potentiation of NMDA receptor function by metabotropic glutamate receptors (mGluRs) of group I occurring postsynaptically. Since release-enhancing NMDA receptors exist on noradrenergic terminals and group I mGluRs have recently been identified on these nerve endings, we have investigated if NMDA receptor-mGluR interactions also can occur at the presynaptic level. EXPERIMENTAL APPROACH: Rat hippocampus and human neocortex synaptosomes were labelled with [(3)H]noradrenaline and superfused with mGluR agonists and antagonists. NMDA-evoked [(3)H]noradrenaline release was produced by removal of external Mg(2+) or by simultaneous application of NMDA and AMPA in Mg(2+)-containing solutions. KEY

resultsThe mGluR1/5 agonist 3,5-DHPG, inactive on its own, potentiated both the release of [(3)H]noradrenaline elicited by AMPA/NMDA/glycine and that evoked by NMDA/glycine following Mg(2+) removal. The effect of 3,5-DHPG on the AMPA/NMDA/glycine-induced release was insensitive to the mGluR1 antagonist CPCCOEt, but it was abolished by the mGluR5 antagonist MPEP; moreover, it was potentiated by the mGluR5 positive allosteric modulator DFB. When NMDA receptors were activated by Mg(2+) removal, both mGluR5 and mGluR1 contributed to the evoked release, the mGluR-mediated release being blocked only by CPCCOEt and MPEP in combination. Experiments with human neocortex synaptosomes show NMDA receptor-mGluR interactions qualitatively similar to those observed in rodents. CONCLUSIONS AND IMPLICATIONS: Group I mGluRs, both of the mGluR1 and mGluR5 subtypes, co-localize with NMDA receptors on noradrenergic terminals of rat hippocampus and human neocortex. Depending on the mode of activation, NMDA receptors exert differential permissive roles on the activation of presynaptic mGluR1 and mGluR5.

Indexed as

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAnimalsCerebral CortexChromonesFemaleGlycineHippocampusHumansMaleN-MethylaspartateNorepinephrinePresynaptic TerminalsProtein BindingRatsRats, Sprague-DawleyReceptor Cross-Talk3,5-dihydroxyphenylglycine7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl esteralpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidChromonesGlycineGRM5 protein, humanGrm5 protein, ratmetabotropic glutamate receptor type 1N-MethylaspartateNorepinephrineReceptor, Metabotropic Glutamate 5Receptors, AMPAReceptors, Metabotropic GlutamateReceptors, N-Methyl-D-AspartateReceptors, PresynapticResorcinolsTritium

Identifiers

PMID17592518
PMCPMC2042940
OpenAlexW1560289129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.